Published in Cancer Res on July 01, 1988
Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients. Br J Cancer (1999) 5.47
Breast cancer cells have a high capacity to acidify extracellular milieu by a dual mechanism. Clin Exp Metastasis (1997) 1.32
Catalytically inactive human cathepsin D triggers fibroblast invasive growth. J Cell Biol (2005) 1.22
Oestrogenic activity of tamoxifen and its metabolites on gene regulation and cell proliferation in MCF-7 breast cancer cells. Br J Cancer (1989) 0.98
Calcium-binding protein S100P and cancer: mechanisms and clinical relevance. J Cancer Res Clin Oncol (2011) 0.96
Relationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours. Br J Cancer (1991) 0.93
Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma. Oncotarget (2015) 0.92
LRP-1: a checkpoint for the extracellular matrix proteolysis. Biomed Res Int (2013) 0.90
Proteinase inhibitors reduce basement membrane degradation by human breast cancer cell lines. Br J Cancer (1997) 0.88
Increased secretory leukocyte protease inhibitor (SLPI) production by highly metastatic mouse breast cancer cells. PLoS One (2014) 0.85
Alterations in proteolytic activity at low pH and its association with invasion: a theoretical model. Clin Exp Metastasis (1999) 0.85
Upregulation of cathepsin D in the caudate nucleus of primates with experimental parkinsonism. Mol Neurodegener (2011) 0.83
The Potential Role of the Proteases Cathepsin D and Cathepsin L in the Progression and Metastasis of Epithelial Ovarian Cancer. Biomolecules (2015) 0.82
Role of somatic cells on dairy processes and products: a review. Dairy Sci Technol (2014) 0.82
Proliferation Markers and EGF in ACTH-Secreting Adenomas and Carcinomas of the Pituitary. Endocr Pathol (1995) 0.81
Western immunoblotting and enzymatic activity analysis of cathepsin D in human breast cancer cell lines of different invasive potential. Regulation by 17beta-estradiol, tamoxifen and ICI 182,780. Clin Exp Metastasis (1997) 0.81
Cathepsin D in breast secretions from women with breast cancer. Br J Cancer (1993) 0.80
Cathepsin D and epidermal growth factor in human breast cyst fluid. Br J Cancer (1991) 0.79
The feasibility of enzyme targeted activation for amino acid/dipeptide monoester prodrugs of floxuridine; cathepsin D as a potential targeted enzyme. Molecules (2012) 0.78
Cathepsin D assay in ovarian cancer: correlation with pathological features and receptors for oestrogen, progesterone and epidermal growth factor. Br J Cancer (1991) 0.76
Regulation of the human cathepsin E gene by the constitutive androstane receptor. Arch Biochem Biophys (2007) 0.76
CORRELATIONSHIP OF CATHEPSIN D AND TOPOISOMERASE II ALPHA WITH NUCLEAR GRADING IN BREAST CANCERS. Med J Armed Forces India (2011) 0.75
Cathepsin D detected by automated and quantitative immunohistochemistry in breast carcinomas: correlation with overall and disease free survival. J Clin Pathol (1997) 0.75
The clonogenic growth of advanced breast tumour lesions adds no value to that of established clinical prognosticators for survival. Br J Cancer (1993) 0.75
SNAPIN is critical for lysosomal acidification and autophagosome maturation in macrophages. Autophagy (2016) 0.75
A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell (1980) 2.28
Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res (2001) 2.21
Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res (1982) 2.15
Inhibition of breast cancer growth by suramin. J Natl Cancer Inst (1992) 2.10
A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase. Nat Med (2000) 2.01
A novel immunoassay using recombinant allergens simplifies peanut allergy diagnosis. Int Arch Allergy Immunol (2010) 1.80
Cathepsin D: an independent prognostic factor for metastasis of breast cancer. Lancet (1989) 1.77
Estradiol induced proteins in the MCF7 human breast cancer cell line. Biochem Biophys Res Commun (1979) 1.76
Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol (1997) 1.53
Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages: correlation with cytosolic assay. Hum Pathol (1994) 1.52
Food anaphylaxis in schools: evaluation of the management plan and the efficiency of the emergency kit. Allergy (2001) 1.50
Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein. Endocrinology (1986) 1.50
Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res (1989) 1.48
Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells. Proc Natl Acad Sci U S A (1992) 1.48
Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. Oncogene (1990) 1.47
Interest of ImmunoCAP system to recombinant omega-5 gliadin for the diagnosis of exercise-induced wheat allergy. Int Arch Allergy Immunol (2008) 1.46
Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis. Cancer Res (1998) 1.37
Estrogen-induced lysosomal proteases secreted by breast cancer cells: a role in carcinogenesis? J Cell Biochem (1987) 1.36
Overexpression of p21WAF1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene (1995) 1.35
Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells. Cancer Res (1989) 1.34
Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells. Cancer Res (1987) 1.33
Breast cancer cells have a high capacity to acidify extracellular milieu by a dual mechanism. Clin Exp Metastasis (1997) 1.32
Effects of antiestrogens on the estrogen-regulated pS2 RNA and the 52- and 160-kilodalton proteins in MCF7 cells and two tamoxifen-resistant sublines. J Biol Chem (1984) 1.31
Population study of food allergy in France. J Allergy Clin Immunol (2001) 1.30
Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochem Biophys Res Commun (1987) 1.29
Nicotinic receptors in the rat prefrontal cortex: increase in glutamate release and facilitation of mediodorsal thalamo-cortical transmission. Eur J Neurosci (1999) 1.25
Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D). J Clin Endocrinol Metab (1982) 1.20
Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissues. J Biol Chem (1981) 1.20
Effects of plasma estrogen sulfates in mammary cancer cells. Endocrinology (1980) 1.20
A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells. Oncogene (2001) 1.19
MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. Exp Cell Res (1991) 1.19
Breast cancer cell invasiveness: correlation with protein kinase C activity and differential regulation by phorbol ester in estrogen receptor-positive and -negative cells. Int J Cancer (1998) 1.18
Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy (2005) 1.17
FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells. Mol Endocrinol (1998) 1.17
Expression of human sequences related to those of mouse mammary tumor virus. J Virol (1988) 1.16
Cloning and sequencing of the 52K cathepsin D complementary deoxyribonucleic acid of MCF7 breast cancer cells and mapping on chromosome 11. Mol Endocrinol (1988) 1.15
Estrogens and growth factors induce the mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells. Nucleic Acids Res (1988) 1.15
Characterization of the proximal estrogen-responsive element of human cathepsin D gene. Mol Endocrinol (1994) 1.14
Phosphorylation, glycosylation, and proteolytic activity of the 52-kD estrogen-induced protein secreted by MCF7 cells. J Cell Biol (1987) 1.13
The endogenous androgen-regulated sialorphin modulates male rat sexual behavior. Horm Behav (2004) 1.12
The 52-kDa estrogen-induced protein secreted by MCF7 cells is a lysosomal acidic protease. Biochem Biophys Res Commun (1986) 1.12
Differential interaction of nuclear receptors with the putative human transcriptional coactivator hTIF1. J Biol Chem (1997) 1.11
Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles. Cancer Res (1990) 1.10
Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis. J Biol Chem (1993) 1.10
Estrogens increase the expression of fibulin-1, an extracellular matrix protein secreted by human ovarian cancer cells. Proc Natl Acad Sci U S A (1996) 1.10
SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens. J Steroid Biochem Mol Biol (1995) 1.09
The transcriptional response to androgens of the rat VCSA1 gene is amplified by both binary and graded mechanisms. Endocrinology (2001) 1.09
[Occupational asthma due to hard metals hypersensitivity]. Rev Mal Respir (2002) 1.08
Effect of estradiol on the ultrastructure of the MCF7 human breast cancer cells in culture. Cancer Res (1982) 1.08
Why are estrogen-receptor-negative breast cancers more aggressive than the estrogen-receptor-positive breast cancers? Invasion Metastasis (1995) 1.08
Characterization of very acidic phagosomes in breast cancer cells and their association with invasion. J Cell Sci (1994) 1.07
Estradiol and fibulin-1 inhibit motility of human ovarian- and breast-cancer cells induced by fibronectin. Int J Cancer (1998) 1.06
Unliganded and liganded estrogen receptors protect against cancer invasion via different mechanisms. Mol Endocrinol (2000) 1.05
Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells. Mol Endocrinol (1989) 1.05
Food-dependent exercise-induced anaphylaxis--update and current data. Eur Ann Allergy Clin Immunol (2006) 1.04
Mouse mammary tumour virus related sequences are present in human DNA. Nucleic Acids Res (1983) 1.04
Biological and clinical significance of cathepsin D in breast cancer metastasis. Stem Cells (1996) 1.02
A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol. Cancer (1993) 1.02
High-affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metabolite. Mol Cell Endocrinol (1980) 1.02
Immediate hypersensitivity to chlorhexidine: literature review. Eur Ann Allergy Clin Immunol (2004) 1.02
Identification of oleosins as major allergens in sesame seed allergic patients. Allergy (2006) 1.01
Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction. J Clin Invest (1998) 1.01
Steroid hormone receptors. Vitam Horm (1975) 1.00
Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteinase-9 by macrophages in asthma. Lab Invest (1999) 1.00
Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-alpha acquire sensitivity to growth inhibition by retinoids. J Biol Chem (1994) 0.99
Transfected cathepsin D stimulates high density cancer cell growth by inactivating secreted growth inhibitors. Cell Growth Differ (1995) 0.99
The prognostic value of cathepsin D in breast cancer. A long road to the clinic. Eur J Cancer (1996) 0.99
Increased cathepsin D level in the serum of patients with metastatic breast carcinoma detected with a specific pro-cathepsin D immunoassay. Cancer (1997) 0.99
Fatty acid synthetase and its mRNA are induced by progestins in breast cancer cells. J Biol Chem (1987) 0.98
Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells. Proc Natl Acad Sci U S A (1993) 0.98
Dual effects of the progestin R5020 on proteins released by the T47D human breast cancer cells. J Biol Chem (1984) 0.98
Formation of estrogen nuclear receptor in uterus: effect of androgens, estrone and nafoxidine. Biochem Biophys Res Commun (1972) 0.98
Metabolism and protein binding of sex steroids in target organs: an approach to the mechanism of hormone action. Recent Prog Horm Res (1971) 0.97
Severe food anaphylaxis: 107 cases registered in 2002 by the Allergy Vigilance Network. Eur Ann Allergy Clin Immunol (2004) 0.97
Characterization of monoclonal antibodies to the estrogen-regulated Mr 52,000 glycoprotein and their use in MCF7 cells. Cancer Res (1985) 0.96
Tissue inhibitor of metalloproteinase-1 levels in bronchoalveolar lavage fluid from asthmatic subjects. Am J Respir Crit Care Med (1999) 0.96
Cross-allergenicity of peanut and lupine: the risk of lupine allergy in patients allergic to peanuts. J Allergy Clin Immunol (1999) 0.96
Differences between oestrogen receptor activation by oestrogen and antioestrogen. Nature (1981) 0.96
Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer. J Steroid Biochem (1989) 0.96
In vivo effect of anti-estrogens on the localisation and replenishment of estrogen receptor. Mol Cell Endocrinol (1975) 0.96
Localization of mRNAs of two androgen-dependent proteins, SMR1 and SMR2, by in situ hybridization reveals sexual differences in acinar cells of rat submandibular gland. J Histochem Cytochem (1993) 0.95
The antiprogestin RU486 in advanced breast cancer: preliminary clinical trial. Bull Cancer (1987) 0.95
Estradiol stimulates cell growth and secretion of procathepsin D and a 120-kilodalton protein in the human ovarian cancer cell line BG-1. J Clin Endocrinol Metab (1992) 0.95